BCL6-IN-3 is a BCL6 inhibitor with anti-tumor activity, extracted from patent WO2018215801A1 (example 20a). It exhibits a GI50 of 70 nM in SU-DHL4 cells.

2253878-44-1

C24H31ClF2N6O2

508.99

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years